XML 41 R30.htm IDEA: XBRL DOCUMENT

Segment Reporting (Tables)

3 Months Ended

Mar. 31, 2025

Segment Reporting [Abstract]

Schedule of Segment Reporting Information

Segment Reporting for the Quarter Ended March 31, 2025


		Treatment				Services				Segments Total				Corporate ⁽¹⁾				Consolidated Total
Revenue from external customers		$	9,186			$	4,733			$	13,919			$	—			$	13,919
Cost of Goods Sold:
Payroll and benefits expenses			4,437				2,013				6,450				—				6,450
Material and supplies expenses			1,351				—				1,351				—				1,351
Disposal expenses			220				—				220				—				220
Transportation expenses			495				—				495				—				495
Subcontract expenses			—				908				908				—				908
Other cost of goods sold ⁽²⁾			2,433				1,405				3,838				—				3,838
Total cost of goods sold			8,936				4,326				13,262				—				13,262
Gross profit			250				407				657				—				657
Selling, general and administrative expenses (“SG&A”):
Payroll and benefits			873				538				1,411				931				2,342
Other SG&A ⁽³⁾			483				198				681				992				1,673
Total SG&A			1,356				736				2,092				1,923				4,015
Research and development			291				23				314				69				383
Gain on disposal of property and equipment			—				(5	)			(5	)			—				(5	)
Loss from operations		$	(1,397	)		$	(347	)		$	(1,744	)		$	(1,992	)			(3,736	)
Interest income																			335
Interest expense																			(112	)
Interest expense-financing fees																			(20	)
Other income																			33
Loss from continuing operations before taxes																			(3,500	)
Income tax expense																			—
Loss from continuing operations, net of taxes																		$	(3,500	)

Segment Reporting for the quarter ended March 31, 2024


		Treatment				Services				Segments Total				Corporate ⁽¹⁾				Consolidated Total
Revenue from external customers		$	8,709			$	4,908			$	13,617			$	—			$	13,617
Cost of goods sold:
Payroll and benefit expenses			3,751				2,452				6,203				—				6,203
Material and supplies expenses			763				—				763				—				763
Disposal expenses			1,569				—				1,569				—				1,569
Transportation expenses			298				—				298				—				298
Subcontract expenses			—				1,810				1,810				—				1,810
Other cost of goods sold ⁽²⁾			2,380				1,214				3,594				—				3,594
Total cost of goods sold			8,761				5,476				14,237				—				14,237
Gross loss			(52	)			(568	)			(620	)			—				(620	)
SG&A:
Payroll and benefits			670				655				1,325				834				2,159
Other SG&A ⁽³⁾			395				137				532				853				1,385
Total SG&A			1,065				792				1,857				1,687				3,544
Research and development			218				28				246				50				296
Loss from operations		$	(1,335	)		$	(1,388	)		$	(2,723	)		$	(1,737	)			(4,460	)
Interest income																			174
Interest expense																			(116	)
Interest expense-financing fees																			(13	)
Other income																			1
Loss from continuing operations before taxes																			(4,414	)
Income tax benefit																			(956	)
Loss from continuing operations, net of taxes																		$	(3,458	)

⁽¹⁾	Amounts reflect the activity for corporate headquarters not included in the segment reporting information.

⁽²⁾	Other cost of goods sold for each reportable segment includes:
	Treatment - lab, regulatory, maintenance, depreciation and amortization, travel, outside services and general expenses. Services - material and supplies, disposal, transportation, lab, regulatory, maintenance, depreciation and amortization, travel, outside services and general expenses.

⁽³⁾	Other SG&A for each reportable segment and Corporate includes:
	Treatment-depreciation and amortization, travel, outside services, maintenance and general expenses.
	Services- travel, outside services, maintenance and general expenses.
	Corporate-maintenance, depreciation and amortization, travel, public company, outside services and general expenses.

Schedule of depreciation and amortization

The following table presents depreciation and amortization for the three months ended March 31, (in thousand):

		2025				2024
Treatment		$	381			$	366
Services			44				44
Total segment			425				410
Corporate			11				21
Total		$	436			$	431

SCHEDULE OF CAPITAL EXPENDITURES

SCHEDULE OF CAPITAL EXPENDITURES

		2025				2024
Treatment		$	487			$	160
Services			36				84
Total segment			523				244
Corporate			—				—
Total		$	523			$	244